CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,470,000 | +160.5% | 134,401 | +160.2% | 0.00% | – |
| Q3 2020 | $948,000 | +761.8% | 51,655 | +602.2% | 0.00% | – |
| Q2 2020 | $110,000 | +64.2% | 7,356 | +73.7% | 0.00% | – |
| Q1 2020 | $67,000 | -79.4% | 4,236 | -78.8% | 0.00% | – |
| Q4 2019 | $325,000 | +221.8% | 19,985 | +194.0% | 0.00% | – |
| Q3 2019 | $101,000 | +339.1% | 6,797 | +372.3% | 0.00% | – |
| Q2 2019 | $23,000 | -58.2% | 1,439 | -55.5% | 0.00% | – |
| Q1 2019 | $55,000 | -84.5% | 3,235 | -83.9% | 0.00% | – |
| Q4 2018 | $354,000 | -4.1% | 20,041 | -1.2% | 0.00% | – |
| Q3 2018 | $369,000 | -27.6% | 20,291 | -22.2% | 0.00% | – |
| Q2 2018 | $510,000 | +91.0% | 26,088 | +71.2% | 0.00% | – |
| Q1 2018 | $267,000 | +1680.0% | 15,238 | +1072.2% | 0.00% | – |
| Q4 2017 | $15,000 | +7.1% | 1,300 | 0.0% | 0.00% | – |
| Q3 2017 | $14,000 | -74.5% | 1,300 | -79.4% | 0.00% | – |
| Q2 2017 | $55,000 | -86.5% | 6,297 | -81.8% | 0.00% | – |
| Q1 2017 | $406,000 | -57.8% | 34,542 | -52.9% | 0.00% | – |
| Q4 2016 | $962,000 | +2906.2% | 73,384 | +3199.6% | 0.00% | – |
| Q3 2016 | $32,000 | +3100.0% | 2,224 | +4348.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 50 | -47.9% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 96 | -52.9% | 0.00% | – |
| Q4 2015 | $4,000 | -81.0% | 204 | -83.8% | 0.00% | – |
| Q3 2015 | $21,000 | -30.0% | 1,263 | +59.9% | 0.00% | – |
| Q2 2015 | $30,000 | -84.9% | 790 | -87.5% | 0.00% | – |
| Q1 2015 | $199,000 | – | 6,329 | +19078.8% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 33 | -99.0% | 0.00% | – |
| Q3 2014 | $66,000 | – | 3,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|